P380: EX VIVO IMMUNE ACTIVATION WITH THE MACROPHAGE-TARGETING IMMUNOTHERAPY, ANTI-CLEVER-1 ANTIBODY BEXMARILIMAB, IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME. (23rd June 2022) - Aakko, S.; Ylitalo, A.; Kuusanmäki, H.; Björkman, M.; Mandelin, J.; Jalkanen, J.; Fjällskog, M.-L.; Heckman, C.; Hollmén, M.; Kontro, M.